Skip to main content
. 2021 May 25;35(6):e21666. doi: 10.1096/fj.202100540R

FIGURE 2.

FIGURE 2

Levels of docosanoids in the BAL fluids of healthy and COVID‐19 patients. BALs were obtained and processed as described in Methods. Lipids then were extracted and quantitated by LC‐MS/MS. A, Docosanoid biosynthetic pathways. B, Levels of docosapentaenoic acid n‐3 (DPAn‐3) and docosahexaenoic acid (DHA). C,D, Docosanoid levels. E, Proportions of the different docosanoids from panel C and D. Results are from the BALs from 25 healthy subjects and 33 COVID‐19 patients. P values were obtained by performing a Mann‐Whitney test using the GraphPad Prism 9 software: * = P < .05, ** = P < .01, *** = P < .001, **** = P < .0001